CLIA Kit for Vascular Endothelial Growth Factor 145 (VEGF145)

Format

48T, 96T, 96T×5, 96T×10, 96T×100
Detection range

1.37-1,000pg/mL
Application

Chemiluminescent immunoassay for Antigen Detection.
Organism species

Homo sapiens (Human)
Sensitivity

The minimum detectable dose of this kit is typically less than 0.55pg/mL
Sample type

Serum, plasma and other biological fluids
Manual Links
Assay length

2h, 40min
Method

Double-antibody Sandwich
Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Item Name

Vascular Endothelial Growth Factor 145
Description

Aplha, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation. Complex subunit associated factors are involved in hybridoma growth, Eosinohils, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex. NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells.

Gene target

CLIA Kit for Vascular Endothelial Growth Factor 145 VEGF145
Short name

CLIA Kit for Vascular Endothelial Growth Factor 145 (VEGF145)
Alternative name

CLIA reagent to measure Vascular Endothelial Growth Factor 145 (VEGF145)
Alternative technique

kits
Alternative to gene target

v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, C-Kit and CD117 and PBT and SCFR, KIT and IDBG-18980 and ENSG00000157404 and 3815, transferase activity, Extracellular, Kit and IDBG-172083 and ENSMUSG00000005672 and 16590, KIT and IDBG-642326 and ENSBTAG00000002699 and 280832
Tissue

vascular